Understanding Glioma Markers and Treatment Approaches

Exploration of key markers like IDH1 mutation and 1P19Q codilation in gliomas, their impact on tumor behavior, and response to treatments. Detailed examination of grade 1, 2, 3, oligodendroglial, astrocytomas, and glioblastomas, including prognosis, treatment options, and the significance of clinical trials. Emphasis on collaborative neuro-oncology efforts, considerations for age in treatment decisions, and the role of MGMT status in glioblastomas.